SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 287 filers reported holding SAGE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $5,970,000 | +41.5% | 69,010 | 0.0% | 0.00% | +100.0% |
| Q3 2020 | $4,218,000 | -76.7% | 69,010 | -84.1% | 0.00% | -83.3% |
| Q2 2020 | $18,100,000 | -82.9% | 435,311 | -88.2% | 0.01% | -86.0% |
| Q1 2020 | $105,585,000 | -61.7% | 3,676,347 | -3.6% | 0.04% | -54.3% |
| Q4 2019 | $275,338,000 | -46.3% | 3,814,076 | +4.3% | 0.09% | -52.0% |
| Q3 2019 | $513,043,000 | -10.8% | 3,657,016 | +16.5% | 0.20% | -14.4% |
| Q2 2019 | $574,956,000 | – | 3,140,292 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |